Findings indicate treatment efficacy with anti-TNF biologics improving height in pediatric patients with Crohn's disease, highlighting clinical outcomes.
Our findings indicate that anti-TNF biologics are associated with significant short-term height and long-term weight gains in pediatric patients with Crohn's disease, similar to those observed with immunomodulators.
No takes yet. Share an insight, caveat, or question.
Schoepfer et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: